Table 1 Baseline characteristics of patients in the two studied groups
From: The role of left prefrontal transcranial magnetic stimulation in episodic migraine prophylaxis
| Â | Active (n = 14) | Control (n = 19) |
|---|---|---|
Age | 37.4 (11.7) | 32.2 (9.8) |
Females | 13 (92.9%) | 15 |
Family history of migraine | 6 (42.9%) | 8 (42.1%) |
Disease duration (years) | 8.5 (6) | 7 (4) |
Migraine with aura | 2 (14.3%) | 2 (10.5 %) |
Beck Depression Inventory | ||
 Normal | 9 (64.3%) | 17 (89.5) |
 Mild | 2 (14.3%) | 2 (10.5%) |
 Borderline/moderate | 3 (21.4%) | 0 |
Use of prophylaxis | 4 (28.6%) | 6 (31.6%) |
 Propranolol | 3 | 3 |
 Amitryptiline | 1 | 0 |
 Topiramate | 0 | 1 |
 Valproate Na | 0 | 1 |
 Cinnarizine | 0 | 1 |
Migraine attack frequency | 8.2(2.4) | 7.3 (2.9) |
Migraine attack durationa | 15.8 (16.4) | 19.3 (20.4) |
Pain intensity (NPRS) | 8.6 (1.5) | 9.1(1.2) |
Migraine days | 9.3 | (1.9) |
Severe migraine daysb | 7.2 (1.8) | 8.2 (3.2) |
HIT-6 | 73.2 (5.7) | 70.6 (8.1) |
Severe HIT-6 (60 or more) | 13 (92.9%) | 14 (73.7%) |
Number of abortive pills | 15.9 (11.8) | 13.8 (9.5) |